-- Jarden在周五发布的一份报告中指出，新闻集团（ASX：NWS）第三财季业绩“稳健”，展现出强劲增长势头。 该季度，新闻集团的息税折旧摊销前利润同比增长18%，超出Jarden此前2%的预期。道琼斯业务是业绩超预期的关键驱动因素。其调整后税后净利润同比增长20%。 这家投资公司指出，新闻集团的图书出版业务受益于实体书和电子书销量的增长。规模最小的新闻媒体业务表现最差，主要受到《加州邮报》创刊的影响。 Jarden重申对新闻集团的“增持”评级，目标价为46.30澳元。 新闻集团股价在上周五的交易中上涨了4%。
Related Articles
Asia
Regis Resources Says Morgan Stanley, Units Acquire 5.87% Stake
Regis Resources (ASX:RRL) said Morgan Stanley and its subsidiaries became a substantial holder of the firm after acquiring 44.4 million shares, or a 5.87% stake, on Tuesday, according to a Friday Australian bourse filing.
$ASX:RRL
Asia
Jumpcan Pharma's Jianwei Xiaoshi Oral Liquid Added to China's Centralized Procurement Program
Hubei Jumpcan Pharmaceutical's (SHA:600566) Jianwei Xiaoshi Oral Liquid was selected for the National Chinese Patent Medicine's centralized procurement, according to a Friday disclosure to the Shanghai bourse.The drug is used to treat food stagnation and indigestion.During the procurement period, medical institutions will prioritize the use of the selected products, the pharmaceutical company said.
$SHA:600566
Asia
Tabcorp Likely Faces Remediation Costs from Austrac Probe, But Sell-Off Overdone, Jarden Says
Tabcorp Holdings (ASX:TAH) likely faces remediation costs in a new regulatory enforcement investigation, and repeat offender status is also a risk, but neither of those factors justifies the magnitude of the sell-off in the company's stock, Jarden said in a Thursday note.The Australian Transaction Reports and Analysis Center (AUSTRAC) is investigating the company's compliance with anti-money laundering and counter-terrorism financing obligations, citing concerns about its ability to identify and mitigate risks.Jarden noted there is no certainty of a financial penalty as the regulator's disclosure stated that all outcomes are on the table, while previous cases show that a zero-penalty result is possible when the regulator is satisfied with cooperation.AUSTRAC's previous gambling sector penalties have ranged from zero to AU$450 million, the equity research firm said, adding that it views top-line implications for Tabcorp as limited.The company's shares fell sharply after the disclosure of the probe, and at those levels, "the stock appears to be factoring a cost impost well in excess of what the precedent set supports," Jarden said.It maintained an overweight rating on Tabcorp with a target price of AU$1.05, saying it will revisit those assessments if Austrac files civil penalty proceedings or Tabcorp takes on provisions related to the case.The company's shares fell 13% in recent Friday trade.
$ASX:TAH